申请人:CHRONOS THERAPEUTICS LIMITED
公开号:US20170253615A1
公开(公告)日:2017-09-07
The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease, disorder or condition ameliorated by inhibition of a dopamine transporter); and methods of treating patients with such compounds; wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
9
, R
10
, Q, X, Y, Z, A, L, B, m, n and p are as defined herein.